Tyler Dylan-Hyde, Chief Legal Officer at CRISPR Therapeutics AG (CRSP), sold 15,000 shares at $18.90 ($284K) on 2017-12-15, disclosed to the SEC on 2017-12-19.
Open-market sale of $284k CRSP by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRSP | SELL | 2018-01-02 | $840K | — | Filing → |
| CRSP | SELL | 2017-12-27 | $308K | — | Filing → |
| CRSP | SELL | 2017-08-08 | $524K | — | Filing → |